CaliPharms, Inc.
KGET
$0.00
$0.000.00%
09/30/2014 | 06/30/2014 | 03/31/2014 | 09/30/2013 | ||
---|---|---|---|---|---|
Revenue | 60.00K | 33.00K | 19.60K | -- | |
Total Other Revenue | -- | -- | -- | -- | |
Total Revenue | 60.00K | 33.00K | 19.60K | -- | |
Cost of Revenue | 67.40K | 50.80K | 24.80K | -- | |
Gross Profit | -7.40K | -17.90K | -5.30K | -- | |
SG&A Expenses | 224.10K | 162.00K | 328.90K | 184.50K | |
Depreciation & Amortization | -- | -- | -- | -- | |
Other Operating Expenses | -- | -- | -- | -- | |
Total Operating Expenses | 291.50K | 212.80K | 353.80K | 184.50K | |
Operating Income | -231.60K | -179.90K | -334.20K | -184.50K | |
Income Before Tax | -4.18M | -1.31M | -784.00K | -185.00K | |
Income Tax Expenses | -- | -- | -- | -- | |
Earnings from Continuing Operations | -4.18M | -1.31M | -784.00K | -185.00K | |
Earnings from Discontinued Operations | -- | -- | -- | -- | |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | |
Net Income | -4.18M | -1.31M | -784.00K | -185.00K | |
EBIT | -231.60K | -179.90K | -334.20K | -184.50K | |
EBITDA | -- | -- | -- | -- | |
EPS Basic | 0.00 | 0.00 | 0.00 | -- | |
Normalized Basic EPS | 0.00 | 0.00 | 0.00 | -- | |
EPS Diluted | 0.00 | 0.00 | 0.00 | -- | |
Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | -- | |
Average Basic Shares Outstanding | 3.36B | 3.08B | 3.05B | -- | |
Average Diluted Shares Outstanding | 3.36B | 3.08B | 3.05B | -- | |
Dividend Per Share | -- | -- | -- | -- | |
Payout Ratio | -- | -- | -- | -- |